M.Pharmacy I Year II Semester (R22)
This subject will provide a value addition and current requirement for the
students in clinical research and pharmacovigilance. It will teach the students on conceptualizing, designing, conducting, managing and reporting of clinical trials.This subject also focuses on global scenario of pharmacovigilance in different methods that can be used to generate safety data. It will teach the students in developing drug safety data in pre-clinical, clinical phases of drug development and post market surveillance.
Upon completion of the course, the student shall be able to;
Regulatory Perspectives of Clinical Trials: Origin and Principles of International Conference on Harmonization - Good Clinical Practice (ICH- GCP) guidelines Ethical Committee: Institutional Review Board, Ethical Guidelines for Biomedical Research and Human Participant-Schedule Y, ICMR, Informed Consent Process: Structure and content of an Informed Consent Process Ethical principles governing informed consent process
Clinical Trials: Types and Design: Experimental Study- RCT and Non RCT, Observation Study: Cohort, Case Control, Cross sectional Clinical Trial Study Team Roles and responsibilities of Clinical Trial Personnel: Investigator, Study Coordinator, Sponsor, Contract Research Organization and its management.
Clinical Trial Documentation: Guidelines to the preparation of documents, Preparation of protocol, Investigator Brochure, Case Report Forms, Clinical Study Report Clinical Trial Monitoring-Safety Monitoring in CT Adverse Drug Reactions: Definition and types. Detection and reporting methods. Severity and seriousness assessment. predictability and preventability assessment. Management of adverse drug reactions; Terminologies of ADR.
Basic aspects, terminologies and establishment of pharmacovigilance: History and progress of pharmacovigilance, Significance of safety monitoring, Pharmacovigilance in India and international aspects, WHO international drug monitoring Program, WHO and Regulatory terminologies of ADR, evaluation of medication safety, establishing pharmacovigilance centres in Hospitals, Industry and National Programs related to pharmacovigilance. Roles and responsibilities in Pharmacovigilance.
Methods, ADR reporting and tools used in pharmacovigilance: International classification of diseases, International Nonproprietary names for drugs, Passive and Active surveillance, Comparative observational studies, Targeted clinical investigations and Vaccine safety surveillance. Spontaneous reporting system and Reporting to regulatory authorities, Guidelines for ADRs reporting. Argus, Aris G Pharmacovigilance, VigiFlow, Statistical methods for evaluating medication safety data.
Loading Question Papers
Fetching data from database...